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Abstract
This in vitro investigation of the behavior of two types of calcium phosphate glass ceramics on the basis of phosphates
of biogenic or synthetic origin prepared from initial mixtures with different particle size has revealed that some
different factors affect the behavior, namely the phase composition of composite, fraction of open porosity, and
average diameter of pore channels. It was established that the solubility of the composites on the basis of synthetic
calcium phosphates and glass after 2 and 7 days contact with saline composites is the highest among the materials
under study. First of all, this fact is related to the peculiarities of their phase composition, high fraction of open porosity,
and high permeability. As for biogenic hydroxyapatite/glass materials, their solubility is several times lower in spite of
close total porosity. The particle size of initial mixture practically does not affect the material solubility; the latter is only
slightly lower for smaller particles.
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Background
Nowadays, regenerative medicine is one of the most de-
veloping trends in current science. One of its trends is
the development of bioactive materials for replacement
of defective areas of bone tissue [1–23]. Hydroxyapatite
(HA), (Ca10(PO4)6(OH)2), is an analog of mineral com-
ponent of human bone tissue. As it is HA that possesses
high biocompatibility with human organism, many of
the current biomaterial substitutes for bone tissue are
various composites on the basis of HA and/or other cal-
cium phosphate materials such as β-tricalciumphosphate
(β-TCP), β-Ca3(PO4)2, calcium pyrophosphate (Ca2P2O7),
tetracalciumphosphate (TTCP), and Ca4(PO4)2O). [1–4].
Calcium phosphates are known to take a particular pos-
ition among implant materials of various types used in re-
placement of bone tissue thanks to the fact that during
degradation they can be used for formation of new bone
tissue [1]. HA may be of synthetic (SHA) or biogenic
(BHA) origin, herein the latter is a natural nanostructured
material that keeps polyporous micro- and nanostructure
of natural bone tissue [5, 6, 20, 21]. Besides, bioactive glass
exhibits biological activity as well and is capable to resorb
and be replaced with newly formed bone tissue [7–9]; so
does bioglass ceramic [17–19].
By today, there have been developed a number of
composite materials based on HA and glass (HA/glass),
where SHA and BHA as well as other materials on the
basis of calcium and phosphor are used as a calcium
phosphate component [10–15, 20–22]. All bioactive
materials after implantation resorb with a definite rate
(depending on the phase composition and structure)
followed by replacement of them with newly formed
bone tissue. Furthermore, bioceramics characterized by
controlled resorption rate can be successfully used as
carriers for local drug delivery [7].
In 2010, Marc Bohner described two main approaches
used in control of the resorption rate of implant materials
for replacement of bone tissue [1]. One is based on the
material pore structure modification, in particular on the
presence of big enough interconnected pores and chan-
nels. Such a porous structure may permit penetration of
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bone cells, including cell precursors of bone tissue, into
blood vessels and thus makes it possible for a material to
steadily resorb and so to form new bone tissue. The other
approach is based on the chemical composition of mater-
ial which can modify as well. For instance, over recent
years in the field of calcium phosphate materials, interest
has shifted from sintered HA to more thermodynamically
reactive compounds such as HA/β-tricalcium phosphate
(TCP), β-TCP, α-TCP, octocalciumphosphate, dehydrate-
dicalcium phosphate, and waterless dicalcium phosphate.
Also, Marc Bohner has indicated that the mechanism
of material resorption may be different [1]. Some mate-
rials such as HA and β-TCP dissolve under the action of
osteoclasts (cells participating in permanent remodeling
a human skeleton) and can release some amount of
hydrochlonic acid onto the surface of material, which
provokes local pH change and calcium phosphate dissol-
ution. Materials of complex composition can resorb
through a combination of some mechanisms, which may
be inherent for calcium phosphate ceramics or compos-
ite ceramics. Among them, namely calcium phosphates,
for example HA and β-TCP, are characterized by the
presence of self-controlling mechanism during cell re-
sorption of material, which consists in releasing calcium
ions and phosphate ions under the action of osteoclasts,
which reduces their activity.
To sum up, important properties of a bioactive mater-
ial are as follows: chemical composition, porosity, and its
structure as they significantly affect the behavior of the
material under the in vivo conditions. A starting stage of
estimation of material bioactivity is in vitro investigation
of the material behavior under the conditions of direct
contact with a model medium that is an analog of in-
ternal medium of organism. As usual, saline and blood
serum are used as such model media. There have been
developed various procedures for estimation of bioactiv-
ity of new materials in these media, starting from studies
of change in model medium pH during its contact with
a material and material dissolution via weight control
during some time.
The aim of the work is to investigate in vitro the be-
havior of two types of calcium phosphate ceramics on
the basis of phosphates of biogenic and synthetic origin
with different particle size of initial mixture, which can
make it possible to compare the structural and chemical
approaches in developing biomaterials.
Methods
Sample Preparation
Bioactive glass-ceramic composites based on nanostruc-
tured biogenic hydroxyapatite (BHA) or synthetic calcium
phosphates mixture (SCPM) with addition of sodium boro-
silicate glass (mass% 49.10 SiO2; 28.14 Na2O; 22.76 B2O3)
were prepared as described in [22, 23]. Glass-ceramic
composite HA/glass materials were produced using pow-
ders of nanostructured BHA (or SCPM) and sodium boro-
silicate glass with a mass ratio of 0.46:1.0. Powder mixture
for SCP/glass composites were produced by mixing sodium
borosilicate glass and SCPM (Ca10(PO4)6(OH)2, Ca2P2O7,
Ca4(PO4)2O and Ca2P2O7) powders (<160 μm). To prepare
a BHA/glass mixture, BHA and sodium borosilicate glass
were used with two different particle sizes: namely <50 μm
(composite BHA/glass-50) and <160 μm (composite BHA/
glass). Compact samples of 3 g and 15 mm diameter were
fabricated by dry pressing under a pressure of 150 MPa and
sintering at 800 °C for all composites studied.
Characterization Methods
Structure
The structure of the composites was studied by scanning
electron microscopy (SEM) using a REM-106I (VAT
SELMI, Ukraine) microscope and analyzed with the spe-
cial material science complex program for analysis of
structure images SIAMS-600 (SIAMS-Ltd, Russia).
Porosity
The composite samples were examined for the apparent
density and total and open porosity (Θt and Θop).The total






where ρap is the apparent density, grams per cubic
centimeter;
ρpikn is the pycnometric density of compact material,
grams per cubic centimeter.
For BHA ρpikn = 3.00 g/cm
3.
In order to determine the open porosity, a sample was
weighted and saturated with ethylene in vacuum. The
saturated samples were weighted in water and in air.
The open porosity of samples (%) was calculated by the
formula:
Θop ¼ m1−mð Þ  ρw= m1−m2ð Þ  ρliq
where m is the sample weight in air, grams;
m1 is the saturated sample weight in air, grams;
m2 is the saturated sample weight in water, grams;
ρw is the density of water, grams per cubic centimeter;
ρliq is the density of the saturating liquid (ethylene),
grams per cubic centimeter.
The closed porosity of samples was calculated by the
formula:
Θcal ¼ Θt‐ Θop
The structure permeability was determined on the
basis of the permeability coefficient which markedly
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affects the mass transport rate in the course of deter-
mination of the dissolution rate in vitro.
k ¼ Θop  r2=8 δ
where Θop is the open porosity;
r is the pore channel radius;
δ is the tortuosity of capillary-porous structure.
Based on the data on pore distribution obtained in
examination of microstructure of various glass ceramics,
average diameters of pore channels of capillary-porous
structures were determined. Taking into account the re-
sults for pore size distribution, in further calculations,
average diameters for the fracture surface were used as
most explicit ones.
In Vitro Bioactivity Testing
Investigation of solubility in vitro of porous samples
was carried out in an isotonic saline solution (0.9%
NaCl) at a solid/liquid ratio of 1:30 after 2 and 7 days
exposition in a thermostat at 36.5 ± 0.5 °C followed by
determination of mass loss on an analytic balance
“OHAUS Pioneer PA214C” (“OHAUS Corporation,”
China) with an accuracy of 0.0001 g.
Results and Discussion
The results of the study of the phase composition of
composites are shown in Fig. 1. It was established that
HA keeps its phase composition in BHA/glass compos-
ites. In the case of SCP/glass composites, where mixture
of synthetic calcium phosphates was used as a calcium
phosphate component, formation of glass ceramics
(calcium silicate, sodium calcium silicates, melilite, so-
dium silicate, sodium borate, HA) took place.
Figures 2 and 3 represent the microstructure of surface
and fracture of composites studied. One can see a sig-
nificant difference in the surface and fracture for all of
samples studied, which is clearly seen in BHA/glass
composites and somewhat slighter in SCP/glass ones.
The fracture microstructure is characterized by more
porous structure compared to that of the surface, which
may be the result of the surface «vitrification» under
sintering, that is, prevailance of glass phase on the
surface rather than in the volume. The type of initial
phosphate component markedly affects the formation of
Fig. 1 XRD patterns for different types of glass-ceramic composites obtained at 800 °C [22, 23]
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Fig. 2 Surface microstructure of different types of glass-ceramic composites
Fig. 3 Fracture surface microstructure of different types of glass-ceramic composites
Pinchuk et al. Nanoscale Research Letters  (2017) 12:111 Page 4 of 8
microstructure and sintering of composites, in particular
their grain shape. In the course of phase transformations
in bioceramics, needle-like grains are formed sizing
within 1.0–19.5 μm, which is characterizing for wollas-
tonite, whereas in BHA/glass composites, individual
grains are hardly distinguished due to the material
vitrification. In addition, the microstructure of both sur-
face and fracture is characterized by decrease in pore
size with decreasing the initial particle size. As a whole,
it is evident that the microstructure of the internal part
of samples is polyporous, in other words, it is character-
ized by the presence of multi-sized pores, which is
promising in view of the achievement of high resorption
properties of bioceramics under direct contact with
human organism media.
Figure 4 demonstrates the data on the apparent density
of bioceramics obtained. As seen, the apparent density is
much affected by both the particle size of initial mixture
and the type of calcium phosphate component. The ap-
parent density of the BHA/glass composite is the highest.
The investigation results for the total porosity and its
open and closed fractions are presented in Fig. 5. As
seen, the total porosity of samples is 32.5–34.5% and
practically does not depend on the type of phosphate
component and particle size of initial mixture. However,
in BHA/glass materials, a closed porosity prevails,
whereas in SCP/glass ones—open porosity. The latter
can be attributed to running processes of phase forma-
tions in synthetic calcium phosphates under sintering
accompanied by gas formation, which leads to the ob-
tained porosity structure. As for BHA/glass materials
prepared from initial mixtures of different particle size,
their porosity falls in a narrow range close to that of
SCP/glass materials. The fraction of open porosity in
these materials is also much lower and practically does
not depend on the particle size of initial mixture.
In determination of solubility in vitro, also of import-
ance is the permeability of porous structure, which
depends rather on open porosity, which is effective dur-
ing material impregnation, and the construction of
capillary-porous channels, characterized by high tortuos-
ity, than on the porosity as a whole and the structure of
pores. Generally, the permeability of structure is deter-
mined by the permeability coefficient, which significantly
influences the mass transport rate in determination of
the dissolution rate in vitro.
The average diameters of pore channels established
through examination of microstructure and pore size
distribution were equal to 4.6, 4.7, and 8.83 μm for
BHA/glass-50, BHA/glass, and SCP/glass, respectively.
Structure change for materials with the same compos-
ition and different initial particle size (BHA/glass) can
be estimated mathematically using relations for perme-
ability coefficients:
k1=k2 ¼ Θop1  dav1ð Þ2  δ2=Θop2  dav2ð Þ2  δ1
For limit cases:
(1) at δ2/δ1 = 1, k1/k2 = (0.026 × (4.6)
2)/(0.045 × (4.7)2) =
0.553;
(2) at δ2/δ1 = 1.5, k1/k2 = (0.026 × (4.6)
2) × 1.5/(0.045 ×
(4.7)2) = 0.829.
The relations give k1 = 0.553 × k2 and k1 = 0.829 × k2
for (1) and (2) cases, respectively.
For a tortuosity of δ = 1.2–1.6, calculation yields
k2= (0.045 × (4.7)
2/4)/(8 × 1.2) = 0.026 μm2, herein k1
for the structure BHA/glass-50 is lower, namely within
k1 = 0.553 × 0.026 = 0.014 μm
2 (1); k1 = 0.829 × 0.026 =
0.021 μm2 (2).
For the capillary-porous structure of the SCP/glass
composite where open porosity dominates (24.1%), at
different values of tortuosity, the permeability is
equal to k3 = (0.241 × (8.83)
2/4)/(8 × 1.2) = 0,489 μm2 and
k3 = (0.241 × (8.83)
2/4)/(8 × 1.6) = 0.367 μm2.
Fig. 4 Apparent density of different types of glass-ceramic composites
Fig. 5 Porosity structure of different types of glass-ceramic composites
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As seen, in the case of similar tortuosity, the perme-
ability of the SCP/glass composites is much higher as
compared to the other structures studied (k3/k2 = 0.489/
0.026 ≈ 19), which is a significant factor, in addition to
the composite phase composition, for interpretation of
different behavior of porous materials after saturation
and solution in vitro.
Investigation of saline pH change during the first
hours upon immersion of composite samples (Fig. 6)
showed a sharper change in saline pH after contact with
the SCP/glass composite as compared to the BHA/glass
composites. Therefore, one may conclude that it is the
type of phosphate component that plays an important
part in primary estimation of sample solubility in vitro.
Herein, comparison of change in saline pH for samples
with different initial particle size has revealed that de-
crease in the particle size very slightly increases saline
pH change.
Further changes in saline pH, after 48 h contact with
samples, confirmed the observed tendency within the ini-
tial 2 h (Fig. 7). The highest pH = 10.2 is achieved by the
SCP/glass composite, which was expected yet after 2 h
immersion. The BHA/glass composites have much lower
pH which is not over 8.1. In addition, such a relation is
confirmed: the lower particle size of initial mixture, the
more significant pH change. The results obtained after
124 h contact with samples demonstrate change in saline
pH depending on the phosphate component used. Also,
the BHA/glass composites go on increasing pH up to 8.4–
8.6 depending on the initial mixture composition. Unlike
in SCP/glass composite, another tendency is observed: pH
decreases down to 9.5. A conclusion can therefore be
made that for 168 h a maximal pH for SCP/glass is
achieved at 48 h observation, whereas for BHA/glass com-
posites this occurred at 168 h.
Generally, concerning changes in saline pH due to con-
tact with composite samples, the following conclusion can
be drawn: SCP/glass composites promote more rapid and
marked change in saline pH than BHA/glass composites
do, which is conditioned, to addition to other important
factors, by more complex phase composition, including
the presence of various phases of calcium phosphate
(calcium silicate, sodium calcium silicates, melilite, sodium
silicate, sodium borate, HA), some of which possess higher
solubility as compared to BHA. This is consistent with the
data of [19], where the solubility orders: glassy phase >
CaSiO3 > α-Ca3(PO4)2 > β-Ca3(PO4)2, that is the presence
of CaSiO3 in SCP/glass composite promotes an increase
in the dissolution rate. This fact may be responsible for
the pH sharp increase in SCP/glass composites after 48 h
and its further slight decrease, because high-solubility
phases dissolve earlier.
Investigation in vitro after 2 and 7 days saline ex-
position of all of the composites studied revealed
that SCP/glass composites have the highest solubility
(7.5%mass/day) (Fig. 8). At very close total porosity,
solubility of BHA/glass composites is several times
lower, which may be related not only to the differ-
ence in the phase composition but also to the struc-
ture of porosity, in particular to higher fraction of
open porosity in SCP/glass composites compared to
BHA/glass ones (Fig. 5). The particle size of initial
mixture slightly influences the solubility of BHA/
glass composites: the solubility of composite with a
particle size of initial mixture of <50 μm is some
lower than that of composite with a particle size of
<160 μm.
Moreover, it was established that at a higher solubility of
SCP/glass composites as a whole, the highest solubility
was fixed for 2 days saline exposition. After 7 days, this
parameter decreased by three times. Unlikely, solubility of
BHA/glass composites increased with increasing the time
Fig. 6 Saline pH change for different types of glass-ceramic composites
samples for 120 min sample immersion
Fig. 7 Saline pH after contact with composite samples for different
types of glass-ceramic composites (48 and 168 h)
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of contact with saline, which can be conditioned by the
peculiarities of composite pore structure as well.
Conclusions
In vitro investigation of two types of calcium phosphate
ceramics of biogenic and synthetic origin with different
particle size of initial mixture has shown that several dif-
ferent factors influence the behavior of composites
during dissolution in vitro. The following factors signifi-
cantly influence the solubility of composite materials
with close composition and different type of calcium
phosphate component under the same conditions: phase
composition, total porosity, fraction of open porosity,
and average diameter of pore channels.
Investigation of composite solubility in vitro after 2
and 7 days contact with saline has established that SCP/
glass composites have the highest solubility among ma-
terials studied. First of all, this may be related to the pe-
culiarities of their phase composition, high fraction of
open porosity, and high permeability. The solubility of
BHA/glass composites is several times lower despite the
fact that their total porosity is close to that of SCP/glass
materials. The particle size of initial mixture practically
does not affect the solubility of BHA/glass composites
but it is slightly lower for composites with lower particle
size (<50 μm). The highest solubility was fixed within
2 days contact with saline, and after 7 days, this param-
eter decreased by three times. In contrast, solubility of
BHA/glass composites increases with increasing the
contact time, which may be assigned to the peculiarities
of the composite pore structure.
The carried out investigation has demonstrated that
the studied composites meet all of the principal require-
ments for implant materials and are promising in
replacement of bone tissue. In particular, SCP/glass
materials may be recommended as carriers of drugs when
it is necessary to release high doses of drugs, for example
antibiotics, during first 2 days after operation. As for
BHA/glass materials, they are promising for application as
carriers when it is necessary to prolong release of drugs.
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